192 related articles for article (PubMed ID: 37761391)
1. The Current Role of the sFlt-1/PlGF Ratio and the Uterine-Umbilical-Cerebral Doppler Ultrasound in Predicting and Monitoring Hypertensive Disorders of Pregnancy: An Update with a Review of the Literature.
Chirilă CN; Mărginean C; Chirilă PM; Gliga ML
Children (Basel); 2023 Aug; 10(9):. PubMed ID: 37761391
[TBL] [Abstract][Full Text] [Related]
2. Ophthalmic artery Doppler at 36 weeks' gestation in prediction of pre-eclampsia: validation and update of previous model.
Mansukhani T; Wright A; Arechvo A; Laich A; Iglesias M; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2024 Feb; 63(2):230-236. PubMed ID: 37616530
[TBL] [Abstract][Full Text] [Related]
3. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 19-23 weeks' gestation.
Sapantzoglou I; Wright A; Arozena MG; Campos RV; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Jan; 57(1):75-83. PubMed ID: 33142353
[TBL] [Abstract][Full Text] [Related]
5. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
7. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre-eclampsia at 35-37 weeks' gestation.
Sarno M; Wright A; Vieira N; Sapantzoglou I; Charakida M; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Apr; 57(4):600-606. PubMed ID: 33073902
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ophthalmic artery Doppler with PlGF and sFlt-1/PlGF ratio at 35-37 weeks' gestation in prediction of imminent pre-eclampsia.
Lau K; Wright A; Sarno M; Kametas NA; Nicolaides KH
Ultrasound Obstet Gynecol; 2022 May; 59(5):606-612. PubMed ID: 35132725
[TBL] [Abstract][Full Text] [Related]
11. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.
Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A
Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845
[TBL] [Abstract][Full Text] [Related]
12. Stratification of pregnancy care based on risk of pre-eclampsia derived from biophysical and biochemical markers at 19-24 weeks' gestation.
Litwinska M; Litwinska E; Astudillo A; Syngelaki A; Wright A; Nicolaides KH
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):360-368. PubMed ID: 33794058
[TBL] [Abstract][Full Text] [Related]
13. Is a sFlt-1/PlGF cutoff of 38 suitable to predict adverse outcomes in pregnancies with abnormal uterine artery Doppler velocimetry in the second trimester?
Álvarez SC; Zurita AR; Del Carmen De Ganzo Suárez T; De Luis Escudero JF; Medina NS; Pérez CC; de Basoa CMF; Montesino JLT; Masip MTC; Bello MÁG
Pregnancy Hypertens; 2023 Dec; 34():13-18. PubMed ID: 37778280
[TBL] [Abstract][Full Text] [Related]
14. Prediction of preeclampsia and induced delivery at <34 weeks gestation by sFLT-1 and PlGF in patients with abnormal midtrimester uterine Doppler velocimetry: a prospective cohort analysis.
Stubert J; Ullmann S; Bolz M; Külz T; Dieterich M; Richter DU; Reimer T
BMC Pregnancy Childbirth; 2014 Aug; 14():292. PubMed ID: 25169665
[TBL] [Abstract][Full Text] [Related]
15. Uterine artery Doppler and sFlt-1/PlGF ratio: usefulness in diagnosis of pre-eclampsia.
Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Gómez-Montes E; Denk B; Galindo A
Ultrasound Obstet Gynecol; 2013 May; 41(5):530-7. PubMed ID: 23303638
[TBL] [Abstract][Full Text] [Related]
16. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
[TBL] [Abstract][Full Text] [Related]
17. sFlt-1/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow.
Quezada MS; Rodríguez-Calvo J; Villalaín C; Gómez-Arriaga PI; Galindo A; Herraiz I
Ultrasound Obstet Gynecol; 2020 Oct; 56(4):549-556. PubMed ID: 31840879
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
19. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic factors vs Doppler surveillance in the prediction of adverse outcome among late-pregnancy small-for- gestational-age fetuses.
Lobmaier SM; Figueras F; Mercade I; Perello M; Peguero A; Crovetto F; Ortiz JU; Crispi F; Gratacós E
Ultrasound Obstet Gynecol; 2014 May; 43(5):533-40. PubMed ID: 24203115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]